Miko NV (LON:0F99)
51.60
+0.40 (0.78%)
At close: Aug 4, 2025
Verve Therapeutics Market Cap
Miko NV has a market cap or net worth of 55.25 million as of August 6, 2025. Its market cap has increased by 2.78% in one year.
Market Cap
55.25M
Enterprise Value
117.37M
Revenue
257.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
$51.60
Market Cap Chart
Since March 1, 1999, Miko NV's market cap has increased from 42.00M to 55.25M, an increase of 31.54%. That is a compound annual growth rate of 1.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 6, 2025 | 55.25M | 4.24% |
Dec 31, 2024 | 53.00M | -12.19% |
Dec 29, 2023 | 60.36M | -39.12% |
Dec 30, 2022 | 99.15M | -7.27% |
Dec 31, 2021 | 106.92M | -2.45% |
Dec 31, 2020 | 109.61M | -2.66% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 172.68B |
HSBC Holdings | 160.27B |
Shell | 157.58B |
Unilever | 112.01B |
Rolls-Royce Holdings | 91.69B |
British American Tobacco p.l.c. | 91.44B |
Rio Tinto Group | 76.42B |
RELX PLC | 71.41B |